{"count": 5, "results": [{"_id": "33133704", "pmid": 33133704, "pmcid": "PMC7591977", "title": "Type IV RTA in Chronic Adrenal Insufficiency and Concomitant Lisinopril Treatment", "journal": "Case Rep Endocrinol", "authors": ["Galbiati F"], "date": "2020-10-19T00:00:00Z", "doi": "10.1155/2020/8897112", "meta_date_publication": "2020", "meta_volume": "2020", "meta_issue": "", "meta_pages": "8897112", "score": 50282.285, "text_hl": "@DISEASE_Hypoaldosteronism @DISEASE_MESH:D006994 @@@Type IV RTA@@@ in @<m>DISEASE_Adrenal_Insufficiency</m> @DISEASE_MESH:D000309 @@@Chronic Adrenal Insufficiency@@@ and Concomitant @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ Treatment", "citations": {"NLM": "Galbiati F. Type IV RTA in Chronic Adrenal Insufficiency and Concomitant Lisinopril Treatment Case Rep Endocrinol. 2020;2020():8897112. PMID: 33133704", "BibTeX": "@article{33133704, title={Type IV RTA in Chronic Adrenal Insufficiency and Concomitant Lisinopril Treatment}, author={Galbiati F}, journal={Case Rep Endocrinol}, volume={2020}, pages={8897112}}"}}, {"_id": "7669880", "pmid": 7669880, "title": "[Lisinopril in the treatment of heart insufficiency].", "journal": "An Med Interna", "authors": ["Barcina Sánchez C", "Martín Cortés M", "Fernández Fernández A"], "date": "1995-05-01T00:00:00Z", "meta_date_publication": "1995 May", "meta_volume": "12", "meta_issue": "5", "meta_pages": "246-53", "score": 50100.43, "text_hl": "[@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ in the treatment of @<m>DISEASE_Adrenal_Insufficiency</m> @DISEASE_MESH:D000309 @@@heart insufficiency@@@].", "citations": {"NLM": "Barcina Sánchez C, Martín Cortés M, Fernández Fernández A. [Lisinopril in the treatment of heart insufficiency]. An Med Interna. 1995 May;12(5):246-53. PMID: 7669880", "BibTeX": "@article{7669880, title={[Lisinopril in the treatment of heart insufficiency].}, author={Barcina Sánchez C and Martín Cortés M and Fernández Fernández A}, journal={An Med Interna}, volume={12}, number={5}, pages={246-53}}"}}, {"_id": "2176346", "pmid": 2176346, "title": "[The value of lysinopril in cardiac insufficiency].", "journal": "Rev Prat", "authors": ["Lambert M", "Luccioni R"], "date": "1990-10-11T00:00:00Z", "meta_date_publication": "1990 Oct 11", "meta_volume": "40", "meta_issue": "23 Suppl", "meta_pages": "53-8", "score": 50100.43, "text_hl": "[The value of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lysinopril@@@ in @<m>DISEASE_Adrenal_Insufficiency</m> @DISEASE_MESH:D000309 @@@cardiac insufficiency@@@].", "citations": {"NLM": "Lambert M, Luccioni R. [The value of lysinopril in cardiac insufficiency]. Rev Prat. 1990 Oct 11;40(23 Suppl):53-8. PMID: 2176346", "BibTeX": "@article{2176346, title={[The value of lysinopril in cardiac insufficiency].}, author={Lambert M and Luccioni R}, journal={Rev Prat}, volume={40}, number={23 Suppl}, pages={53-8}}"}}, {"_id": "11933558", "pmid": 11933558, "title": "[Heart failure and vasopeptidase inhibitors].", "journal": "Arch Mal Coeur Vaiss", "authors": ["Bareiss P", "Ohlmann P", "Roul G"], "date": "2002-02-01T00:00:00Z", "meta_date_publication": "2002 Feb", "meta_volume": "95 Spec 4", "meta_issue": "5 Spec 4", "meta_pages": "51-3", "score": 50058.746, "text_hl": "In the IMPRESS study, @CHEMICAL_omapatrilat @CHEMICAL_MESH:C106266 @@@omapatrilat@@@ has been evaluated in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Adrenal_Insufficiency</m> @DISEASE_MESH:D000309 @@@cardiac insufficiency@@@ versus @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@; there was no significant difference on the principal outcome measure which was exercise tolerance, however it was significantly more effective than @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ on the outcome measure combining @DISEASE_Death @DISEASE_MESH:D003643 @@@death@@@ and hospital admission for deteriorating @<m>DISEASE_Adrenal_Insufficiency</m> @DISEASE_MESH:D000309 @@@cardiac insufficiency@@@. ", "citations": {"NLM": "Bareiss P, Ohlmann P, Roul G. [Heart failure and vasopeptidase inhibitors]. Arch Mal Coeur Vaiss. 2002 Feb;95 Spec 4(5 Spec 4):51-3. PMID: 11933558", "BibTeX": "@article{11933558, title={[Heart failure and vasopeptidase inhibitors].}, author={Bareiss P and Ohlmann P and Roul G}, journal={Arch Mal Coeur Vaiss}, volume={95 Spec 4}, number={5 Spec 4}, pages={51-3}}"}}, {"_id": "12793058", "pmid": 12793058, "title": "[Administration of maximal or median doses of drugs in cardiovascular diseases?].", "journal": "Vnitr Lek", "authors": ["Spácil J"], "date": "2003-04-01T00:00:00Z", "meta_date_publication": "2003 Apr", "meta_volume": "49", "meta_issue": "4", "meta_pages": "322-5; discussion 326-7", "score": 50046.66, "text_hl": "This applies e.g. to the study HOT with @CHEMICAL_Felodipine @CHEMICAL_MESH:D015736 @@@felodipine@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ and @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Adrenal_Insufficiency</m> @DISEASE_MESH:D000309 @@@cardiac insufficiency@@@ in the ATLAS study with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and the MERIT-HF study with @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@. ", "citations": {"NLM": "Spácil J. [Administration of maximal or median doses of drugs in cardiovascular diseases?]. Vnitr Lek. 2003 Apr;49(4):322-5; discussion 326-7. PMID: 12793058", "BibTeX": "@article{12793058, title={[Administration of maximal or median doses of drugs in cardiovascular diseases?].}, author={Spácil J}, journal={Vnitr Lek}, volume={49}, number={4}, pages={322-5; discussion 326-7}}"}}]}